| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |